SEC Form 4 · accession 0001209191-16-129343
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Director
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $26.07 | Jun 21, 2016 | A | 20,000 | A | — | Jun 21, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option becomes exercisable as to 25% of the shares on June 21, 2017, and becomes exercisable as to 1/48th of the shares each full month thereafter.